“Currently, GLP-1 receptor agonists like Ozempic are not licensed to treat alcohol cravings,” warned Dr David McLaughlan, a consultant psychiatrist and addictions specialist at Priory and co-founder of Curb.health.
Search
News Archives
News Signup
FREE: daily or weekly news supporting freedom from dependency
Journal signup
FREE: print journal and emag supporting freedom from dependency
Conference savings
MONEY OFF: for signups
Support our work
To support us giving the recovery field FREE daily news+research, FREE library, FREE journal and subsidised conference training, click the secure Donate link. THANK YOU!
Recent News
